PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Chest10.1016/j.chest.2021.07.125020211604A1367PLEURAL PATHOLOGY AMONG HOSPITALIZED PATIENTS WITH COVID-19ARITRA SEN, MAHER TABBAhttps://api.elsevier.com/content/article/PII:S001236922102701X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S001236922102701X?httpAccept=text/plain
Jurnal Respirologi Indonesia10.36497/jri.v42i1.278202242119-27Analysis of Comorbidity and Its Association with Disease Severity and Mortality Rate in Hospitalized COVID-19 PatientsAnthony Christanto, Aditya Sri Listyoko, Ngakan Putu Parsama Putrahttp://jurnalrespirologi.org/index.php/jri/article/viewFile/278/pdf, http://jurnalrespirologi.org/index.php/jri/article/viewFile/278/pdf
10.21203/rs.3.rs-54298/v12020Impact of comorbidity burden on mortality in patients with COVID-19: a retrospective analysis of the Korean health insurance databaseSoo Ick Cho, Susie Yoon, Ho-Jin Leehttps://www.researchsquare.com/article/rs-54298/v1, https://www.researchsquare.com/article/rs-54298/v1.html
European Journal of Medical and Health Sciences10.24018/ejmed.2021.3.6.113120213678-81Vitamin D Levels among Hospitalized and Non-Hospitalized COVID-19 Patients in Dr. M. Djamil General Hospital PadangHarika Putra, Efrida, Rismawati Yaswirhttps://www.ej-med.org/index.php/ejmed/article/download/1131/678, https://www.ej-med.org/index.php/ejmed/article/download/1131/678
Jurnal PROMKES10.20473/jpk.v9.i2.2021.168-176202192168Analysis of COVID-19 Prevention Behaviour among Diabetes Mellitus Comorbidity Patients in PalembangGiszka Putri, Hamzah Hasyim, Nur Alam Fajarhttps://e-journal.unair.ac.id/PROMKES/article/viewFile/29175/15613, https://e-journal.unair.ac.id/PROMKES/article/viewFile/29175/15613
Frontiers in Medicine10.3389/fmed.2022.85053620229Age, Sex, and Race/Ethnicity in Clinical Outcomes Among Patients Hospitalized With COVID-19, 2020Jusung Leehttps://www.frontiersin.org/articles/10.3389/fmed.2022.850536/full
Scientific Reports10.1038/s41598-021-85813-22021111Impact of comorbidity burden on mortality in patients with COVID-19 using the Korean health insurance databaseSoo Ick Cho, Susie Yoon, Ho-Jin Leehttp://www.nature.com/articles/s41598-021-85813-2.pdf, http://www.nature.com/articles/s41598-021-85813-2, http://www.nature.com/articles/s41598-021-85813-2.pdf
Open Forum Infectious Diseases10.1093/ofid/ofab466.64020218Supplement_1S322-S323441. The Effects of Race and Comorbidity Burden on Inflammatory Biomarkers Among Persons Hospitalized with COVID-19Yetunde A Fatade, Lauren F Collins, Lauren F Collins, Zakaria Almuwaqqat, ZhenChao Chen, Mahadev Prasad, Arshed Quyyumi, Igho Ofotokunhttps://academic.oup.com/ofid/article-pdf/8/Supplement_1/S322/41526407/ofab466.640.pdf, https://academic.oup.com/ofid/article-pdf/8/Supplement_1/S322/41526407/ofab466.640.pdf
Infection & Chemotherapy10.3947/ic.2020.01492021532300Association of Early Favipiravir Use with Reduced COVID-19 Fatality among Hospitalized PatientsErcan Karatas, Lacin Aksoy, Ersin Ozaslanhttps://icjournal.org/pdf/10.3947/ic.2020.0149, https://icjournal.org/DOIx.php?id=10.3947/ic.2020.0149, https://icjournal.org/DOIx.php?id=10.3947/ic.2020.0149
European Heart Journal10.1093/eurheartj/ehaa935202041464389-4390The widely promoted antimalarial drug hydroxychloroquine confers no mortality benefit in hospitalized patients with COVID-19: comment on the ‘Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19’Giovanna Liuzzo, Carlo Patronohttp://academic.oup.com/eurheartj/article-pdf/41/46/4389/36177561/ehaa935.pdf, http://academic.oup.com/eurheartj/article-pdf/41/46/4389/36177561/ehaa935.pdf